quantity structureact relationship sar approach classis use predict compound activeinact rel overall biology active antitumor antibiotic active use data set pubchem empire cd descriptor semiempir quantumchem active pharmacist ingredi admit extra valid best model screen marin micro natur product antimarin database four lead drug design propos respect present work enable present new possible like bioactiv corridor result previous investing side shown use discrimin biology intact none suggest assign nonantibiot nonantitumor almost late report literature 